Company intelligence / Profile preview

Endocision Technologies

Montréal, Quebec, Canada

Ownership: Private
Development stage: Other

Overview

The Endocision cryobiopsy probe has demonstrated the ability to obtain lung tissue samples comparable to current surgical standards, but with less invasiveness and improved safety, in ex-vivo human lung studies

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

Participated in MedTech Innovator 2023 accelerator program

Beyond the preview

Go deeper on Endocision Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Endocision Technologies.

Explore the full profile